Tiliroside protects against diabetic nephropathy in streptozotocin-induced diabetes rats by attenuating oxidative stress and inflammation

Figure 2 Effect of Tiliroside on initial and final body weight of experimental rats. A: Initial body weight; B: Final body weight. Data are given as the mean ± SD of three individual values. All results were statistically assessed by one-way ANOVA and Tukey’s post hoc test. ^aP < 0.05 vs Control; ^bP < 0.01 vs STZ. GB: Glibenclamide; TIL: Tiliroside; STZ: Streptozotocin.